We have also identified CD8+ T‐cell responses against HLA‐E‐restricted SARS‐CoV2 Spike and nonstructural (NS) epitopes in convalescent COVID19 patients [34, 35], thus validating that this approach can reliably identify epitopes that are naturally presented by HLA‐E in vivo. The gene discussed is HLA-E; the disease is COVID-19.